You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.
CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.
Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.
In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.
According to the Wall Street Journal, Becton Dickinson is investigating reports from nursing homes regarding false positive results from its rapid COVID-19 test.
Technology Review reports synthetic biologists are developing an attenuated SARS-CoV-2 to use in a vaccine.
The Associated Press reports on challenges faced by Black scientists during fieldwork.
In Genome Biology this week: improved reference genome for the Asian tiger mosquito Aedes albopictus, links between Ebola variants and outcomes, and more.
Reuters reports that a number of researchers have sent a letter to The Lancet critiquing its recent Russian COVID-19 vaccine paper.
According to the Los Angeles Times, National Institutes of Health officials are concerned about the possible side effect reported by a COVID-19 vaccine trial.
The New York Times reports the New York Genome Center has awarded six grants to researchers to study cancer in diverse populations.
In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.
The editor-in-chief of Science criticizes President Donald Trump for downplaying the COVID-19 pandemic risk.
Politico reports that political appointees are interfering with what appears in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Reports.
After a pause, AstraZeneca has resumed its COVID-19 vaccine clinical trial in the UK, according to NPR.
In PLOS this week: functional effect of adiponectin-linked variants, sequencing reveals regional differences among Swedes, and more.
A genetic analysis of Australian labradoodles finds they are mostly poodles, the Guardian reports.
Court documents suggest Theranos' Elizabeth Holmes' defense team might rely on "expert evidence relating to a mental disease or defect," CNN reports.
Maryland has ordered 250,000 rapid coronavirus tests, according to the Washington Post.
In Science this week: additional variants linked to development of primary lymphedema, and more.
The Washington Post reports AstraZeneca's pausing of its candidate vaccine trial indicates the science is being followed.
Researchers have uncovered more than 175 open-access journals that have disappeared from the internet, Science reports.